ALK and non-small cell lung carcinoma: In the field of ALK-TKIs for NSCLC, in addition to terms such as “ALK-TKI” and “lung adenocarcinoma,” the prominent keywords are primarily associated with three major research areas: drug resistance mechanisms, circulating tumor DNA, and immunotherapy.